JP2009520769A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520769A5
JP2009520769A5 JP2008546470A JP2008546470A JP2009520769A5 JP 2009520769 A5 JP2009520769 A5 JP 2009520769A5 JP 2008546470 A JP2008546470 A JP 2008546470A JP 2008546470 A JP2008546470 A JP 2008546470A JP 2009520769 A5 JP2009520769 A5 JP 2009520769A5
Authority
JP
Japan
Prior art keywords
phenyl
allyloxy
propynyl
acetic acid
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008546470A
Other languages
English (en)
Japanese (ja)
Other versions
JP5054028B2 (ja
JP2009520769A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/070096 external-priority patent/WO2007071766A2/en
Publication of JP2009520769A publication Critical patent/JP2009520769A/ja
Publication of JP2009520769A5 publication Critical patent/JP2009520769A5/ja
Application granted granted Critical
Publication of JP5054028B2 publication Critical patent/JP5054028B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008546470A 2005-12-22 2006-12-21 新規化合物、それらの製造および使用 Active JP5054028B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05112758 2005-12-22
EP05112758.7 2005-12-22
EP06115631 2006-06-19
EP06115631.1 2006-06-19
PCT/EP2006/070096 WO2007071766A2 (en) 2005-12-22 2006-12-21 Phenoxy acetic acids as ppar delta activators

Publications (3)

Publication Number Publication Date
JP2009520769A JP2009520769A (ja) 2009-05-28
JP2009520769A5 true JP2009520769A5 (enrdf_load_stackoverflow) 2011-11-24
JP5054028B2 JP5054028B2 (ja) 2012-10-24

Family

ID=38055174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546470A Active JP5054028B2 (ja) 2005-12-22 2006-12-21 新規化合物、それらの製造および使用

Country Status (14)

Country Link
US (8) US7943613B2 (enrdf_load_stackoverflow)
EP (2) EP1979311B1 (enrdf_load_stackoverflow)
JP (1) JP5054028B2 (enrdf_load_stackoverflow)
KR (1) KR101265078B1 (enrdf_load_stackoverflow)
CN (1) CN103224477A (enrdf_load_stackoverflow)
AU (1) AU2006327003B2 (enrdf_load_stackoverflow)
BR (1) BRPI0620468A2 (enrdf_load_stackoverflow)
CA (1) CA2631390C (enrdf_load_stackoverflow)
EA (3) EA201101084A1 (enrdf_load_stackoverflow)
ES (1) ES2386734T3 (enrdf_load_stackoverflow)
IL (1) IL191655A (enrdf_load_stackoverflow)
NZ (1) NZ568488A (enrdf_load_stackoverflow)
TW (1) TWI389878B (enrdf_load_stackoverflow)
WO (1) WO2007071766A2 (enrdf_load_stackoverflow)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1763511B1 (en) * 2004-05-05 2010-07-28 High Point Pharmaceuticals, LLC Phenoxyacetic acid derivatives as ppar agonists
EP1745014B1 (en) * 2004-05-05 2011-07-06 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
JP5054028B2 (ja) * 2005-12-22 2012-10-24 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー 新規化合物、それらの製造および使用
ITMI20071261A1 (it) * 2007-06-22 2008-12-23 Dipharma Francis Srl Procedimento per la preparazione di cinacalcet
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP2013006769A (ja) * 2009-10-08 2013-01-10 Nippon Chemiphar Co Ltd ペルオキシソーム増殖剤活性化受容体の活性化剤
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP5929109B2 (ja) * 2011-11-11 2016-06-01 デクセリアルズ株式会社 新規なエチニルベンゾフェノン化合物類又はその類縁体
JP6049891B2 (ja) * 2013-09-05 2016-12-21 株式会社日立製作所 ストレージシステム及び記憶制御方法
ES2811087T3 (es) * 2013-09-09 2021-03-10 Vtv Therapeutics Llc Uso de agonistas de PPAR-delta para tratar la atrofia muscular
GB201318886D0 (en) * 2013-10-25 2013-12-11 Givaudan Sa Improvements i or relating to organic compounds
AU2020224129A1 (en) * 2019-02-20 2021-10-07 Reneo Pharmaceuticals, Inc. Use of PPAR-delta agonists in the treatment of mitochondrial myopathy
JP2022548725A (ja) * 2019-09-20 2022-11-21 レネオ ファーマシューティカルズ，インク． 腎臓病の治療におけるｐｐａｒデルタアゴニストの使用
JP2023534835A (ja) * 2020-07-22 2023-08-14 レネオ ファーマシューティカルズ，インク． 結晶性ｐｐａｒデルタアゴニスト
MX2023006123A (es) * 2020-11-25 2023-06-02 Reneo Pharmaceuticals Inc Metodos para elaborar un agonista de ppar-delta.
WO2023147309A1 (en) 2022-01-25 2023-08-03 Reneo Pharmaceuticals, Inc. Use of ppar-delta agonists in the treatment of disease
CN120529903A (zh) 2023-01-29 2025-08-22 西玛贝医药公司 慢性瘙痒性皮肤病的治疗
WO2024159048A1 (en) 2023-01-29 2024-08-02 Cymabay Therapeutics, Inc. Treatment of uremic pruritus

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2331336A1 (fr) * 1975-11-14 1977-06-10 Rolland Sa A Acides oxy-4,4' bis(phenoxy-2 alcanocarboxyliques), leurs derives et leur application comme medicament
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US5324743A (en) * 1992-12-10 1994-06-28 Eli Lilly And Company Leukotriene B4 antagonists
IL109451A0 (en) * 1993-04-29 1994-07-31 Zeneca Ltd Heterocyclic derivatives
KR19990077319A (ko) 1996-01-17 1999-10-25 한센 핀 베네드, 안네 제헤르 축합된 1,2,4-티아디아진 및 축합된 1,4-티아진 유도체, 그것의제조방법 및 사용
DE69728267T2 (de) 1996-02-02 2005-02-24 Merck & Co., Inc. Antidiabetisches mittel
AU1856997A (en) 1996-02-02 1997-08-22 Merck & Co., Inc. Method for raising hdl cholesterol levels
EP0888278B1 (en) 1996-02-02 2003-07-23 Merck & Co., Inc. Antidiabetic agents
ES2194179T3 (es) 1996-02-02 2003-11-16 Merck & Co Inc Derivados heterociclicos como agentes antidiabeticos y antiobesidad.
JP2000504021A (ja) 1996-02-02 2000-04-04 メルク エンド カンパニー インコーポレーテッド 糖尿病及び関連疾患状態を治療する方法
AU2652397A (en) 1996-05-13 1997-12-05 Nippon Shinyaku Co. Ltd. Substituted ethylene compounds and drugs
US5773469A (en) * 1996-06-18 1998-06-30 Ortho Pharmaceutical Corporation Diaryl antimicrobial agents
WO1997048876A1 (en) 1996-06-21 1997-12-24 Smith International, Inc. Rolling cone bit having gage and nestled gage cutter elements having enhancements in materials and geometry to optimize borehole corner cutting duty
CA2264243C (en) 1996-08-30 2004-10-05 Novo Nordisk A/S Glp-1 derivatives
CA2275394A1 (en) 1996-12-23 1998-07-02 Merck & Co., Inc. Antidiabetic agents
WO1999001423A1 (en) 1997-07-01 1999-01-14 Novo Nordisk A/S Glucagon antagonists/inverse agonists
BR9810592A (pt) 1997-07-16 2000-09-12 Novo Nordisk As Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
JP4427825B2 (ja) 1997-07-24 2010-03-10 アステラス製薬株式会社 コレステロール低下作用を有する医薬組成物
EP1030665A4 (en) 1997-10-17 2002-11-27 Aventis Pharm Prod Inc THERAPEUTIC USE OF CHINOLINE DERIVATIVES
US6972294B1 (en) * 1999-04-20 2005-12-06 Novo Nordisk, A/S Compounds, their preparation and use
RU2001131111A (ru) 1999-04-20 2003-08-10 Ново Нордиск А/С (DK) Новые соединения, их получение и применение
AU3507700A (en) * 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using diphenylether derivatives
GB9914977D0 (en) 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
US6368155B1 (en) 1999-07-16 2002-04-09 Molex Incorporated Intelligent sensing connectors
TWI262185B (en) 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
US6369098B1 (en) 1999-10-05 2002-04-09 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
CA2390932A1 (en) 1999-11-10 2001-05-17 Takeda Chemical Industries, Ltd. Body weight gain inhibitors
HK1050132A1 (zh) 1999-11-11 2003-06-13 Eli Lilly And Company 治疗癌症的溶瘤配方
CN1396903A (zh) 2000-01-28 2003-02-12 诺沃挪第克公司 新颖的化合物、它们的制备和用途
US6555577B1 (en) * 2000-01-28 2003-04-29 Novo Nordisk A/S Compounds, their preparation and use
EP1254102A1 (en) 2000-01-28 2002-11-06 Novo Nordisk A/S Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
US6569901B2 (en) * 2000-01-28 2003-05-27 Novo Nordisk A/S Alkynyl-substituted propionic acid derivatives, their preparation and use
AU784722B2 (en) 2000-02-18 2006-06-01 Merck & Co., Inc. Aryloxyacetic acids for diabetes and lipid disorders
IL151517A0 (en) 2000-03-09 2003-04-10 Aventis Pharma Gmbh Therapeutic uses of ppar mediators
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
JP2001354671A (ja) 2000-04-14 2001-12-25 Nippon Chemiphar Co Ltd ペルオキシソーム増殖剤応答性受容体δの活性化剤
AU2001248279A1 (en) 2000-04-17 2001-10-30 Novo-Nordisk A/S New compounds, their preparation and use
AU2001263924A1 (en) 2000-05-18 2001-11-26 Novo-Nordisk A/S Fertilization of aged oocytes
CN1338310A (zh) 2000-08-10 2002-03-06 清华大学 一种猪瘟病毒表位疫苗及其制备方法
AU2001277723A1 (en) 2000-08-11 2002-02-25 Nippon Chemiphar Co., Ltd. Ppardelta activators
US6982278B2 (en) * 2000-08-23 2006-01-03 Eli Lilly And Company Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
US6630504B2 (en) * 2000-08-31 2003-10-07 Pfizer Inc. Phenoxyphenylheterocyclyl derivatives as SSRIs
GB0024361D0 (en) 2000-10-05 2000-11-22 Glaxo Group Ltd Medicaments
JPWO2002046154A1 (ja) 2000-12-05 2004-04-08 日本ケミファ株式会社 ペルオキシソーム増殖剤応答性受容体δの活性化剤
GB0031107D0 (en) 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds
GB0031109D0 (en) 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds
GB0031103D0 (en) 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds
WO2002053547A1 (fr) 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Derives d'acide alcanoique, procede de production et utilisation correspondants
WO2002070011A2 (en) 2001-02-02 2002-09-12 Smithkline Beecham Corporation Treatment of ppar mediated diseases
WO2002076957A1 (fr) 2001-03-23 2002-10-03 Nippon Chemiphar Co.,Ltd. Activateur de recepteur active par les proliferateurs du peroxysome
EP1375484A4 (en) 2001-03-28 2009-08-05 Eisai R&D Man Co Ltd CARBOXYLIC ACIDS
WO2002080899A1 (fr) 2001-03-30 2002-10-17 Eisai Co., Ltd. Agent de traitement de maladie digestive
TWI311133B (en) 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
JPWO2002098840A1 (ja) 2001-06-04 2004-09-16 エーザイ株式会社 カルボン酸誘導体及びその塩もしくはそのエステルからなる医薬
NL1018283C2 (nl) 2001-06-13 2002-12-19 Dsm Nv Werkwijze voor het in contact brengen van gesmolten ureum met een gasstroom.
FR2826574B1 (fr) 2001-06-29 2005-08-26 Oreal Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles
CA2452665A1 (en) 2001-07-30 2003-02-13 Lone Jeppesen Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
US6869967B2 (en) * 2001-07-30 2005-03-22 Novo Nordisk A/S Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
WO2003011814A1 (en) 2001-07-30 2003-02-13 Novo Nordisk A/S Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
US7067530B2 (en) * 2001-07-30 2006-06-27 Novo Nordisk A/S Compounds, their preparation and use
DK1424330T3 (da) 2001-08-10 2012-01-16 Nippon Chemiphar Co Aktivator for peroxisom proliferator-responsiv receptor delta
EP1452521A4 (en) 2001-08-17 2007-03-14 Eisai R&D Man Co Ltd CYCLIC COMPOUND AND AGONIST OF PPAR RECEPTOR
BR0212512A (pt) * 2001-09-14 2004-10-26 Tularik Inc Composto, composição farmacêutica e métodos para tratar um distúrbio, condição ou doença, elevar os nìveis do colesterol hdl, reduzir os nìveis de triglicerìdeo, tratar diabete, diminuir a resistência à insulina ou diminuir a pressão arterial e modular a ppardelta
WO2003033493A1 (fr) 2001-10-12 2003-04-24 Nippon Chemiphar Co.,Ltd. Activateur du recepteur $g(d) active par le proliferateur de peroxisome
US7220877B2 (en) * 2001-10-17 2007-05-22 Novo Nordisk A/S Compounds, their preparation and use
KR20050036876A (ko) 2001-10-17 2005-04-20 노보 노르디스크 에이/에스 디카르복실산 유도체, 그것의 제제 및 치료에의 사용
DE10151390A1 (de) 2001-10-18 2003-05-08 Bayer Ag Essigsäurederivate
JP2003171275A (ja) 2001-12-11 2003-06-17 Sumitomo Pharmaceut Co Ltd ＰＰＡＲδアゴニスト
ES2290439T3 (es) 2002-02-25 2008-02-16 Eli Lilly And Company Moduladores del receptor activado del proliferador de peroxisomas.
JP4383177B2 (ja) 2002-03-01 2009-12-16 スミスクライン ビーチャム コーポレーション ｈＰＰＡＲ活性化剤
US6833380B2 (en) 2002-03-07 2004-12-21 Warner-Lambert Company, Llc Compounds that modulate PPAR activity and methods of preparation
US20030207924A1 (en) 2002-03-07 2003-11-06 Xue-Min Cheng Compounds that modulate PPAR activity and methods of preparation
US6867224B2 (en) 2002-03-07 2005-03-15 Warner-Lambert Company Compounds that modulate PPAR activity and methods of preparation
US6875780B2 (en) 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation
DE10222034A1 (de) 2002-05-17 2003-11-27 Bayer Ag Tetrahydroisochinolin-Derivate
GB0214149D0 (en) 2002-06-19 2002-07-31 Glaxo Group Ltd Chemical compounds
GB0214254D0 (en) 2002-06-20 2002-07-31 Glaxo Group Ltd Chemical compounds
EP1524997A1 (en) 2002-06-26 2005-04-27 Pharmacia Corporation Stable liquid parenteral parecoxib formulation
DE10229777A1 (de) 2002-07-03 2004-01-29 Bayer Ag Indolin-Phenylsulfonamid-Derivate
WO2004007439A1 (ja) 2002-07-10 2004-01-22 Sumitomo Pharmaceuticals Co., Ltd. ビアリール誘導体
CN1688540A (zh) 2002-09-05 2005-10-26 诺沃挪第克公司 新颖的乙烯基羧酸衍生物以及它们的治疗用途
PL376325A1 (en) 2002-10-21 2005-12-27 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes
US7129268B2 (en) * 2002-10-28 2006-10-31 Novo Nordisk A/S Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
JP4708184B2 (ja) 2002-10-28 2011-06-22 ハイ ポイント ファーマシューティカルズ，エルエルシー 新規の化合物、それらの調製及び使用
US20050080115A1 (en) * 2002-10-28 2005-04-14 Lone Jeppesen Novel compounds, their preparation and use
ATE469882T1 (de) * 2002-10-28 2010-06-15 High Point Pharmaceuticals Llc Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen
EP1585733A1 (en) 2003-01-06 2005-10-19 Eli Lilly And Company Heterocyclic ppar modulators
DE10300099A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Indol-Phenylsulfonamid-Derivate
CN1751037A (zh) 2003-02-14 2006-03-22 伊莱利利公司 作为ppar调节剂的磺酰胺衍生物
WO2004080943A1 (ja) 2003-03-11 2004-09-23 Ono Pharmaceutical Co., Ltd. シンナミルアルコール誘導体化合物およびその化合物を有効成分として含有する薬剤
CN1787989A (zh) 2003-03-13 2006-06-14 小野药品工业株式会社 亚氨醚衍生化合物和含有该化合物作为活性成分的药物
CA2521175A1 (en) 2003-04-07 2004-10-28 Kalypsys, Inc. Para-sulfonyl substituted phenyl compounds as modulators of ppars
JP2006523698A (ja) 2003-04-17 2006-10-19 カリプシス・インコーポレーテッド Ｐｐａｒ変調薬としての（３−｛３−（２，４−ビス−トリフルオロメチル−ベンジル）−（５−エチル−ピリミジン−２−イル）−アミノ−プロポキシ｝−フェニル）−酢酸および関連化合物、ならびに代謝性障害の処置方法
US7244763B2 (en) 2003-04-17 2007-07-17 Warner Lambert Company Llc Compounds that modulate PPAR activity and methods of preparation
EP1620422A2 (en) 2003-04-30 2006-02-01 The Institutes for Pharmaceutical Discovery, LLC Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
US20070082907A1 (en) 2003-11-25 2007-04-12 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
WO2005097096A1 (en) 2004-03-31 2005-10-20 Pharmacia & Upjohn Company Llc A phenyl acetic acid cyclooxygenase-2 inhibitor for the treatment of ocular disorders
CA2561230A1 (en) 2004-04-01 2005-10-20 Aventis Pharmaceuticals Inc. 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof
AU2005231358A1 (en) 2004-04-01 2005-10-20 Aventis Pharmaceuticals Inc. Use of PPR delta agonists for treating demyelinating diseases
NZ550857A (en) 2004-04-01 2009-12-24 Aventis Pharma Inc 1,3,4-oxadiazol-2-ones as PPAR delta modulators
JPWO2005097782A1 (ja) 2004-04-07 2007-08-16 協和醗酵工業株式会社 ピペリジン誘導体
EP1763511B1 (en) * 2004-05-05 2010-07-28 High Point Pharmaceuticals, LLC Phenoxyacetic acid derivatives as ppar agonists
EP1745014B1 (en) 2004-05-05 2011-07-06 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
ATE486838T1 (de) * 2004-05-05 2010-11-15 High Point Pharmaceuticals Llc Neue verbindungen, ihre herstellung und verwendung
WO2007003581A1 (en) * 2005-06-30 2007-01-11 Novo Nordisk A/S Phenoxy acetic acids as ppar delta activators
JP5054028B2 (ja) * 2005-12-22 2012-10-24 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー 新規化合物、それらの製造および使用
US7943612B2 (en) * 2006-03-09 2011-05-17 High Point Pharmaceuticals, Llc Compounds that modulate PPAR activity, their preparation and use
FR2898271B1 (fr) 2006-03-09 2009-01-16 Pierre Fabre Medicament Sa Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
WO2007141295A1 (en) 2006-06-08 2007-12-13 High Point Pharmaceuticals, Llc Process for preparing phenoxy acetic acid derivatives
ES2811087T3 (es) * 2013-09-09 2021-03-10 Vtv Therapeutics Llc Uso de agonistas de PPAR-delta para tratar la atrofia muscular

Similar Documents

Publication Publication Date Title
JP2009520769A5 (enrdf_load_stackoverflow)
JP2004520292A5 (enrdf_load_stackoverflow)
JP2004529174A5 (enrdf_load_stackoverflow)
JP2009541270A5 (enrdf_load_stackoverflow)
JP2012533546A5 (enrdf_load_stackoverflow)
JP2004534035A5 (enrdf_load_stackoverflow)
JP2004518702A5 (enrdf_load_stackoverflow)
JP2007511485A5 (enrdf_load_stackoverflow)
JP2009531280A5 (enrdf_load_stackoverflow)
JP2010523476A5 (enrdf_load_stackoverflow)
JP2008518890A5 (enrdf_load_stackoverflow)
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
JP2005528348A5 (enrdf_load_stackoverflow)
JP2009531376A5 (enrdf_load_stackoverflow)
JP2008523126A5 (enrdf_load_stackoverflow)
JP2009528275A5 (enrdf_load_stackoverflow)
JP2016514109A5 (enrdf_load_stackoverflow)
JP2008537547A5 (enrdf_load_stackoverflow)
JP2002513793A5 (enrdf_load_stackoverflow)
JP2004507501A5 (enrdf_load_stackoverflow)
JP2003523938A5 (enrdf_load_stackoverflow)
JP2009537559A5 (enrdf_load_stackoverflow)
JP2009519227A5 (enrdf_load_stackoverflow)
JP2005521721A5 (enrdf_load_stackoverflow)
JP2013531070A5 (enrdf_load_stackoverflow)